Atlas Trials

The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL

Clinical trial NCT00441025 · TERMINATED

Trial details

NCT number
NCT00441025
Sponsor
Mahidol University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T-Cell Lymphoma
Start date
2006-09-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.